Skip to Main Content

Paper Details

Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA).
Adv Ther (Weinh)
10
2020
Anti-CD40 Antibody, CD8+, CD8+ T-cell, MBTA, Metastatic Tumors, T-cell, TLR Ligands, anti-CD40 antibody, colon carcinoma, parental cell line, toll-like receptor ligands, tumor, tumor cells, tumors, whole tumor cell vaccine
Author NameAffiliation
Tianxia WuNational Institute of Neurological Disorders and Stroke, National Institutes of Health
Masaki TerabeNational Cancer Institute, National Institutes of Health
Karel PacakEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
Zhengping ZhuangNational Cancer Institute, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2